(Q37600503)

English

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

scientific article published on 15 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study (English)

1 reference

Europe PubMed Central

21 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Axel Gerdtsson

6

0 references

object named as

Hans Lilja

12

0 references

object named as

Andrew J Vickers

1

0 references

author name string

David Ulmert

2

1 reference

Europe PubMed Central

21 August 2017

Daniel D Sjoberg

3

1 reference

Europe PubMed Central

21 August 2017

Caroline J Bennette

4

1 reference

Europe PubMed Central

21 August 2017

Thomas Björk

5

1 reference

Europe PubMed Central

21 August 2017

Jonas Manjer

7

1 reference

Europe PubMed Central

21 August 2017

Peter M Nilsson

8

1 reference

Europe PubMed Central

21 August 2017

Anders Dahlin

9

1 reference

Europe PubMed Central

21 August 2017

Anders Bjartell

10

1 reference

Europe PubMed Central

21 August 2017

Peter T Scardino

11

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

15 April 2013

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

346

1 reference

Europe PubMed Central

21 August 2017

f2023

1 reference

Europe PubMed Central

21 August 2017

Prostate-cancer mortality at 11 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Germline mutations in HOXB13 and prostate-cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Clinical risk factors, DNA variants, and the development of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Validity of a Population-Based Cancer Register in Sweden An Assessment of Data Reproducibility in the South-East Region Prostate Cancer Register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

23 August 2017

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

6 September 2017

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

6 September 2017

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

6 September 2017

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

25 June 2018

Towards an optimal interval for prostate cancer screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

1 September 2018

Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

1 September 2018

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

1 September 2018

Balancing the harms and benefits of early detection of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

1 September 2018

Elevated prostate-specific antigen levels up to 25 years prior to death from prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933251

1 September 2018

Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-specific reference ranges for serum prostate-specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/23596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.F2023

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37600503&oldid=1667440394"